{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T22:24:57Z","timestamp":1770157497019,"version":"3.49.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Canine osteosarcoma (OSA) causes focal malignant osteolysis leading to severe pain. Despite the documented efficacy of radiotherapy or IV aminobisphosphonates for managing cancer bone pain, their potential combined therapeutic value has not been reported in OSA-bearing dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Pamidronate combined with standardized palliative therapy will improve pain control and bone biologic effects in OSA-bearing dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Fifty dogs with appendicular OSA treated with standardized palliative therapy and either pamidronate or sterile saline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Randomized, prospective, double-blinded, placebo-controlled study. Treatment responses for dogs receiving standardized palliative therapy with (n = 26) or without (n = 24) adjuvant pamidronate were serially evaluated for changes in subjective pain scores, urine N-telopeptide (NTx) excretion, primary tumor relative bone mineral density (rBMD), and computerized pressure platform gait analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median duration of subjective pain relief for dogs treated with adjuvant pamidronate or placebo was 76 and 75 days, respectively (P= .39). Forty percent (20\/50; pamidronate [11\/26] and placebo [9\/24]) of dogs experienced durable analgesia, defined by pain alleviation \u2265112 days. For patients achieving durable pain control, dogs treated with pamidronate achieved greater reductions in NTx excretion and larger increases in rBMD compared with placebo controls. Changes in peak vertical force assessed by computerized pressure platform gait analysis correlated with pain alleviation in OSA-bearing dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Combining pamidronate with standardized palliative therapy is safe, but does not clearly improve pain alleviation. However, in dogs achieving durable pain control, adjuvant pamidronate appears to decrease focal bone resorption in the local tumor microenvironment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1939-1676.2008.0221.x","type":"journal-article","created":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T07:45:38Z","timestamp":1227771938000},"page":"152-160","source":"Crossref","is-referenced-by-count":56,"title":["Double-Blind Placebo-Controlled Trial of Adjuvant Pamidronate with Palliative Radiotherapy and Intravenous Doxorubicin for Canine Appendicular Osteosarcoma Bone Pain"],"prefix":"10.1093","volume":"23","author":[{"given":"T.M.","family":"Fan","sequence":"first","affiliation":[{"name":"University of Illinois at Urbana-Champaign Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.C.","family":"Charney","sequence":"additional","affiliation":[{"name":"University of Illinois at Urbana-Champaign Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.P.","family":"De Lorimier","sequence":"additional","affiliation":[{"name":"H\u00f4pital V\u00e9t\u00e9rinaire Rive-Sud, Brossard , QC, Canada J3L 0A7"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.D.","family":"Garrett","sequence":"additional","affiliation":[{"name":"University of Illinois at Urbana-Champaign Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.","family":"Griffon","sequence":"additional","affiliation":[{"name":"University of Illinois at Urbana-Champaign Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.J.","family":"Gordon-Evans","sequence":"additional","affiliation":[{"name":"University of Illinois at Urbana-Champaign Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Wypij","sequence":"additional","affiliation":[{"name":"University of Illinois at Urbana-Champaign Department of Veterinary Clinical Medicine, , Urbana, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,1,1]]},"reference":[{"key":"2026020304275759600_b1","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/cncr.11144","article-title":"Bone cancer pain","volume":"97","author":"Clohisy","year":"2003","journal-title":"Cancer"},{"key":"2026020304275759600_b2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrc747","article-title":"Molecular mechanisms of cancer pain","volume":"2","author":"Mantyh","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2026020304275759600_b3","first-page":"293","article-title":"Bone cancer pain and the role of RANKL\/OPG","volume":"4","author":"Clohisy","year":"2004","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"2026020304275759600_b4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1667\/RR3108","article-title":"Radiation treatment decreases bone cancer pain, osteolysis and tumor size","volume":"161","author":"Goblirsch","year":"2004","journal-title":"Radiat Res"},{"key":"2026020304275759600_b5","first-page":"4038","article-title":"Osteoprotegerin diminishes advanced bone cancer pain","volume":"61","author":"Luger","year":"2001","journal-title":"Cancer Res"},{"key":"2026020304275759600_b6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1667\/RR3439.1","article-title":"Radiation treatment decreases bone cancer pain through direct effect on tumor cells","volume":"164","author":"Goblirsch","year":"2005","journal-title":"Radiat Res"},{"key":"2026020304275759600_b7","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2460\/javma.2004.225.1567","article-title":"Stereotactic radiosurgery for treatment of osteosarcomas involving the distal portions of the limbs in dogs","volume":"225","author":"Farese","year":"2004","journal-title":"J Am Vet Med Assoc"},{"key":"2026020304275759600_b8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5326\/0380445","article-title":"Four fraction palliative radiotherapy for osteosarcoma in 24 dogs","volume":"38","author":"Green","year":"2002","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020304275759600_b9","first-page":"707","article-title":"Palliative radiation therapy for canine osteosarcoma","volume":"47","author":"Mayer","year":"2006","journal-title":"Can Vet J"},{"key":"2026020304275759600_b10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4102\/jsava.v69i1.802","article-title":"Targeted radiotherapy with Sm-153-EDTMP in nine cases of canine primary bone tumours","volume":"69","author":"Milner","year":"1998","journal-title":"J South Afr Vet Assoc"},{"key":"2026020304275759600_b11","first-page":"713","article-title":"Palliative radiotherapy with electrons of appendicular osteosarcoma in 54 dogs","volume":"19","author":"Mueller","year":"2005","journal-title":"In Vivo"},{"key":"2026020304275759600_b12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1740-8261.1999.tb00385.x","article-title":"Palliative radiotherapy of appendicular osteosarcoma in 95 dogs","volume":"40","author":"Ramirez","year":"1999","journal-title":"Vet Radiol Ultrasound"},{"key":"2026020304275759600_b13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/1097-0142(19910101)67:1<126::AID-CNCR2820670123>3.0.CO;2-7","article-title":"Percent tumor necrosis as a predictor of treatment response in canine osteosarcoma","volume":"67","author":"Powers","year":"1991","journal-title":"Cancer"},{"key":"2026020304275759600_b14","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/1097-0142(19930415)71:8<2484::AID-CNCR2820710810>3.0.CO;2-D","article-title":"Intra-arterial cisplatin with or without radiation in limb-sparing for canine osteosarcoma","volume":"71","author":"Withrow","year":"1993","journal-title":"Cancer"},{"key":"2026020304275759600_b15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2026020304275759600_b16","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"key":"2026020304275759600_b17","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1053\/j.seminoncol.2007.10.006","article-title":"Clinical benefits and considerations of bisphosphonate treatment in metastatic bone disease","volume":"34","author":"Saad","year":"2007","journal-title":"Semin Oncol"},{"key":"2026020304275759600_b18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1939-1676.2005.tb02661.x","article-title":"Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement","volume":"19","author":"Fan","year":"2005","journal-title":"J Vet Intern Med"},{"key":"2026020304275759600_b19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1939-1676.2008.0046.x","article-title":"The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis","volume":"22","author":"Fan","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020304275759600_b20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1939-1676.2007.tb02986.x","article-title":"Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain","volume":"21","author":"Fan","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026020304275759600_b21","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2460\/ajvr.2004.65.1634","article-title":"Assessing repeatability and validity of a visual analogue scale questionnaire for use in assessing pain and lameness in dogs","volume":"65","author":"Hudson","year":"2004","journal-title":"Am J Vet Res"},{"key":"2026020304275759600_b22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jnci\/dji002","article-title":"Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors","volume":"97","author":"Brown","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2026020304275759600_b23","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1200\/JCO.2005.06.091","article-title":"Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid","volume":"23","author":"Coleman","year":"2005","journal-title":"J Clin Oncol"},{"key":"2026020304275759600_b24","first-page":"777","article-title":"Evaluation by dual energy X-ray absorptiometry of changed bone density in metastatic bone sites as a consequence of systemic treatment","volume":"7","author":"Berruti","year":"2000","journal-title":"Oncol Rep"},{"key":"2026020304275759600_b25","first-page":"566","article-title":"Monitoring therapeutic response in skeletal metastases using dual-energy X-ray absorptiometry","volume":"17","author":"Shapiro","year":"1999","journal-title":"A prospective feasibility study in breast cancer patients"},{"key":"2026020304275759600_b26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1010991213842","article-title":"Dual X-ray absorptiometry detects disease- and treatment-related alterations of bone density in prostate cancer patients","volume":"18","author":"Smith","year":"2000","journal-title":"Clin Exp Metastasis"},{"key":"2026020304275759600_b27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1532-950x.2004.04042.x","article-title":"Assessing the efficacy of perioperative oral carprofen after cranial cruciate surgery using noninvasive, objective pressure platform gait analysis","volume":"33","author":"Horstman","year":"2004","journal-title":"Vet Surg"},{"key":"2026020304275759600_b28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1354\/vp.42-2-161","article-title":"Use of alkaline phosphatase staining to differentiate canine osteosarcoma from other vimentin-positive tumors","volume":"42","author":"Barger","year":"2005","journal-title":"Vet Pathol"},{"key":"2026020304275759600_b29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/rvsc.2000.0397","article-title":"Urinary markers of type I collagen degradation in the dog","volume":"69","author":"Allen","year":"2000","journal-title":"Res Vet Sci"},{"key":"2026020304275759600_b30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00223-001-1026-x","article-title":"Biological variability in serum and urinary indices of bone formation and resorption in dogs","volume":"70","author":"Ladlow","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"2026020304275759600_b31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jso.20949","article-title":"Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor-induced osteolysis","volume":"97","author":"Arrington","year":"2008","journal-title":"J Surg Oncol"},{"key":"2026020304275759600_b32","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/cncr.11646","article-title":"Combination of early bisphosphonate administration and irradiation leads to improved remineralization and restabilization of osteolytic bone metastases in an animal tumor model","volume":"98","author":"Krempien","year":"2003","journal-title":"Cancer"},{"key":"2026020304275759600_b33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/0269216307084130","article-title":"Does pamidronate enhance the analgesic effect of radiotherapy? A randomized trial","volume":"21","author":"George","year":"2007","journal-title":"Palliat Med"},{"key":"2026020304275759600_b34","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/jnci\/dji139","article-title":"Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases","volume":"97","author":"Hartsell","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2026020304275759600_b35","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00066-003-0978-3","article-title":"An intra-patient dose-escalation study of disodium pamidronate plus radiotherapy versus radiotherapy alone for the treatment of osteolytic metastases. Monitoring of recalcification using image-processing techniques","volume":"179","author":"Kouloulias","year":"2003","journal-title":"Strahlenther Onkol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.2008.0221.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/23\/1\/152\/66673242\/j.1939-1676.2008.0221.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/23\/1\/152\/66673242\/j.1939-1676.2008.0221.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:28:09Z","timestamp":1770110889000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/23\/1\/152\/8449857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.2008.0221.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009,1]]},"published":{"date-parts":[[2009,1,1]]}}}